{"id":295,"date":"2013-10-24T00:36:33","date_gmt":"2013-10-24T00:36:33","guid":{"rendered":"https:\/\/drugpolicy.ca\/?p=295"},"modified":"2016-01-19T22:22:32","modified_gmt":"2016-01-19T22:22:32","slug":"lifesaving-heroin-assisted-treatment-dealt-serious-blow","status":"publish","type":"post","link":"https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/","title":{"rendered":"Lifesaving Heroin Assisted Treatment Dealt Serious Blow"},"content":{"rendered":"<p><strong>By Connie Carter and Susan Boyd<\/strong><\/p>\n<p>On October 3, 2013, federal Health Minister Rona Ambrose announced new regulations that became effective immediately to prevent Health Canada\u2019s <a href=\"http:\/\/www.hc-sc.gc.ca\/dhp-mps\/acces\/drugs-drogues\/index-eng.php\" target=\"_blank\">Special Access Programme<\/a> from approving the use of prescribed diacetylmorphine* as a treatment for addiction for a small number of patients finishing the clinical trial <a href=\"http:\/\/www.providencehealthcare.org\/salome\/\" target=\"_blank\">SALOME<\/a>, in Vancouver, BC. Health Canada\u2019s Special Access Programme (SAP) allows practitioners to request access to drugs that are unavailable for sale in Canada.<\/p>\n<p>Ambrose\u2019s comments at the October 3rd press conference misrepresented the extensive evidence supporting heroin-assisted treatment (HAT). She claimed HAT is unsafe and expensive and not in keeping with her government\u2019s National Anti-Drug Strategy.\u00a0 Her comments reflected the Harper government\u2019s refusal to acknowledge the eight peer-reviewed research HAT trials worldwide that have found it to be a beneficial, safe, and cost-effective approach for patients where methadone and other conventional treatments have not worked.<\/p>\n<p>Ambrose promoted the virtues of abstinence-based drug treatment failing to mention that Canada\u2019s system of treatment programs is a patchwork of private and public providers. As the CDPC\u2019s report on <a title=\"Getting To Tomorrow: A Report on Canadian Drug Policy\" href=\"\/?p=756\" target=\"_blank\">Canadian drug policy found<\/a>, private treatment programs are expensive, and in the absence of national accreditation standards, these programs can vary in quality. Abstinence based treatment is also ineffective for many people with long-wait times for publicly-funded services.<\/p>\n<p>Ambrose\u2019s press conference included supporters who were called upon to back the federal government\u2019s position. One speaker, Marshall Smith, a former political staffer with the BC Liberal Government, described his own struggles with drugs including crystal meth, and his recovery through abstinence-based treatment. Smith currently works for Cedars at Cobble Hill, a privately run drug treatment facility on Vancouver Island. Smith comes from a self-admitted well-to-do family, who can afford private treatment facilities that can cost upwards of $10,000 a month. Every person\u2019s story of recovery and change is important, but with all due respect to Mr. Smith, it\u2019s vital that no one person\u2019s story stand in for the range of experiences with substance use.<\/p>\n<p>Comments at the press conference reflected a narrow view of recovery from substance dependency and assumed that all people will benefit from conventional drug treatment approaches. In a turn about from previous calls for abstinence-only drug treatment, speakers\u2019 called for expanded opiate-substitution programs like methadone. But HAT is only offered to patients who have failed repeatedly with methadone and abstinence-based programs.<\/p>\n<p>Ambrose called Health Canada\u2019s recent decision to approve the use of diacetylmorphine for 20 patients a \u201cloophole\u201d in the Special Access Program regulations. But the Special Access Program is supposed to provide patients with serious or life-threatening conditions, access to drugs on a compassionate or emergency basis and especially when conventional therapies have failed. Under these conditions, many of the seriously ill patients who enter HAT would certainly qualify for access.<\/p>\n<p>No one knows better the concerns of patients in these research trials than SNAP, an independent Vancouver based group comprised of former and current members of Vancouver based HAT research trials (former NPA). SNAP advocates for human rights and access to appropriate health care for its members and has been working since January 2011 to establish permanent HAT programs. SNAP members also have first hand experience with the use of diacetylmorphine. Their experiences confirm the findings of other research studies that this drug is a proven safe and effective treatment for opiate dependency. Patients\u2019 physical and psychological health improved, accompanied by decreased criminal activity and illegal drug use. Given the positive results from studies around the world and here in Canada, the federal government\u2019s refusal to recognize the best treatment for this small groups of patients is an egregious violation of their rights to access to health care.<\/p>\n<p>* Diacetylmorphine is the active ingredient in heroin. It is pharmaceutical-grade product manufactured by a company outside Canada. For the purposes of research trials, it is purchased and imported with permission of the Government of Canada.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>By Connie Carter and Susan Boyd On October 3, 2013, federal Health Minister Rona Ambrose announced new regulations that became effective immediately to prevent Health Canada\u2019s Special Access Programme from approving the use of prescribed diacetylmorphine* as a treatment for addiction for a small number of patients finishing the clinical trial SALOME, in Vancouver, BC. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2163,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","footnotes":""},"categories":[1,17],"tags":[],"class_list":["post-295","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all","category-harm-reduction"],"acf":[],"mb":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lifesaving Heroin Assisted Treatment Dealt Serious Blow - Canadian Drug Policy Coalition<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lifesaving Heroin Assisted Treatment Dealt Serious Blow - Canadian Drug Policy Coalition\" \/>\n<meta property=\"og:description\" content=\"By Connie Carter and Susan Boyd On October 3, 2013, federal Health Minister Rona Ambrose announced new regulations that became effective immediately to prevent Health Canada\u2019s Special Access Programme from approving the use of prescribed diacetylmorphine* as a treatment for addiction for a small number of patients finishing the clinical trial SALOME, in Vancouver, BC. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta property=\"article:published_time\" content=\"2013-10-24T00:36:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-01-19T22:22:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.canadiandrugpolicy.ca\/wp-content\/uploads\/2013\/10\/RonaAmbrose-Attribution-Number10-changes_Blog_415x415px-S.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"415\" \/>\n\t<meta property=\"og:image:height\" content=\"415\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/dfa227f7f7fb3d70383391c4c01ec657\"},\"headline\":\"Lifesaving Heroin Assisted Treatment Dealt Serious Blow\",\"datePublished\":\"2013-10-24T00:36:33+00:00\",\"dateModified\":\"2016-01-19T22:22:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\\\/\"},\"wordCount\":662,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/new.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2013\\\/10\\\/RonaAmbrose-Attribution-Number10-changes_Blog_415x415px-S.jpg\",\"articleSection\":[\"All\",\"Harm Reduction\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\\\/\",\"url\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\\\/\",\"name\":\"Lifesaving Heroin Assisted Treatment Dealt Serious Blow - Canadian Drug Policy Coalition\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/new.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2013\\\/10\\\/RonaAmbrose-Attribution-Number10-changes_Blog_415x415px-S.jpg\",\"datePublished\":\"2013-10-24T00:36:33+00:00\",\"dateModified\":\"2016-01-19T22:22:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\\\/#primaryimage\",\"url\":\"https:\\\/\\\/new.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2013\\\/10\\\/RonaAmbrose-Attribution-Number10-changes_Blog_415x415px-S.jpg\",\"contentUrl\":\"https:\\\/\\\/new.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2013\\\/10\\\/RonaAmbrose-Attribution-Number10-changes_Blog_415x415px-S.jpg\",\"width\":415,\"height\":415},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lifesaving Heroin Assisted Treatment Dealt Serious Blow\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"name\":\"Canadian Drug Policy Coalition\",\"description\":\"Change policy. Save lives.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Drug Policy Coalition\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"width\":332,\"height\":333,\"caption\":\"Canadian Drug Policy Coalition\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/dfa227f7f7fb3d70383391c4c01ec657\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lifesaving Heroin Assisted Treatment Dealt Serious Blow - Canadian Drug Policy Coalition","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/","og_locale":"fr_FR","og_type":"article","og_title":"Lifesaving Heroin Assisted Treatment Dealt Serious Blow - Canadian Drug Policy Coalition","og_description":"By Connie Carter and Susan Boyd On October 3, 2013, federal Health Minister Rona Ambrose announced new regulations that became effective immediately to prevent Health Canada\u2019s Special Access Programme from approving the use of prescribed diacetylmorphine* as a treatment for addiction for a small number of patients finishing the clinical trial SALOME, in Vancouver, BC. [&hellip;]","og_url":"https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/","og_site_name":"Canadian Drug Policy Coalition","article_published_time":"2013-10-24T00:36:33+00:00","article_modified_time":"2016-01-19T22:22:32+00:00","og_image":[{"width":415,"height":415,"url":"https:\/\/www.canadiandrugpolicy.ca\/wp-content\/uploads\/2013\/10\/RonaAmbrose-Attribution-Number10-changes_Blog_415x415px-S.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/#article","isPartOf":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/"},"author":{"name":"admin","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/dfa227f7f7fb3d70383391c4c01ec657"},"headline":"Lifesaving Heroin Assisted Treatment Dealt Serious Blow","datePublished":"2013-10-24T00:36:33+00:00","dateModified":"2016-01-19T22:22:32+00:00","mainEntityOfPage":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/"},"wordCount":662,"commentCount":0,"publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/#primaryimage"},"thumbnailUrl":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2013\/10\/RonaAmbrose-Attribution-Number10-changes_Blog_415x415px-S.jpg","articleSection":["All","Harm Reduction"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/","url":"https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/","name":"Lifesaving Heroin Assisted Treatment Dealt Serious Blow - Canadian Drug Policy Coalition","isPartOf":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/#primaryimage"},"image":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/#primaryimage"},"thumbnailUrl":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2013\/10\/RonaAmbrose-Attribution-Number10-changes_Blog_415x415px-S.jpg","datePublished":"2013-10-24T00:36:33+00:00","dateModified":"2016-01-19T22:22:32+00:00","breadcrumb":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/#primaryimage","url":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2013\/10\/RonaAmbrose-Attribution-Number10-changes_Blog_415x415px-S.jpg","contentUrl":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2013\/10\/RonaAmbrose-Attribution-Number10-changes_Blog_415x415px-S.jpg","width":415,"height":415},{"@type":"BreadcrumbList","@id":"https:\/\/new.drugpolicy.ca\/fr\/lifesaving-heroin-assisted-treatment-dealt-serious-blow\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drugpolicy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Lifesaving Heroin Assisted Treatment Dealt Serious Blow"}]},{"@type":"WebSite","@id":"https:\/\/www.drugpolicy.ca\/fr\/#website","url":"https:\/\/www.drugpolicy.ca\/fr\/","name":"Canadian Drug Policy Coalition","description":"Change policy. Save lives.","publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drugpolicy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization","name":"Canadian Drug Policy Coalition","url":"https:\/\/www.drugpolicy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","width":332,"height":333,"caption":"Canadian Drug Policy Coalition"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/dfa227f7f7fb3d70383391c4c01ec657","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/new.drugpolicy.ca\/fr\/author\/admin\/"}]}},"mfb_rest_fields":["title","yoast_head","yoast_head_json"],"_links":{"self":[{"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/comments?post=295"}],"version-history":[{"count":0,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/295\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media\/2163"}],"wp:attachment":[{"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media?parent=295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/categories?post=295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/tags?post=295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}